Protalix BioTherapeutics, Inc. (PLX)
AMEX·Healthcare·Biotechnology
$2.12
-1.85%
Mkt Cap $174.03M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 18, 2026 | $18.30M | $9.12M | -50.14% | $0.01 | -$0.07 | -800.00% | — | — |
| Q4 2025 Nov 13, 2025 | $14.24M | $17.85M | +25.32% | $0.06 | $0.03 | -50.00% | — | — |
| Q3 2025 Aug 14, 2025 | $13.49M | $15.66M | +16.11% | $0.03 | $0.00 | -93.27% | — | — |
| Q2 2025 May 9, 2025 | $23.10M | $10.11M | -56.22% | $0.08 | -$0.05 | -162.50% | — | — |
| Q1 2025 Mar 17, 2025 | $21.60M | $18.22M | -15.66% | $0.07 | $0.09 | +28.57% | — | — |
| Q4 2024 Nov 14, 2024 | $18.21M | $17.96M | -1.36% | $0.06 | $0.03 | -50.00% | — | — |
| Q3 2024 Aug 14, 2024 | $3.75M | $13.47M | +259.50% | -$0.01 | -$0.03 | -250.06% | — | — |
| Q2 2024 May 10, 2024 | $9.20M | $3.75M | -59.26% | -$0.02 | -$0.06 | -200.00% | — | — |
| Q1 2024 Mar 14, 2024 | $5.80M | $10.49M | +80.79% | -$0.03 | -$0.07 | -133.33% | — | — |
| Q4 2023 Nov 6, 2023 | $8.12M | $10.35M | +27.40% | -$0.07 | -$0.04 | +42.86% | — | — |
| Q3 2023 Aug 7, 2023 | $18.25M | $35.08M | +92.19% | $0.03 | $0.21 | +624.89% | — | — |
| Q2 2023 May 4, 2023 | — | $9.59M | — | — | -$0.05 | — | — | — |
| Q1 2023 Feb 27, 2023 | $6.12M | $8.62M | +40.80% | -$0.15 | -$0.07 | +53.33% | — | — |
| Q4 2022 Nov 14, 2022 | $5.70M | $14.18M | +149.04% | -$0.15 | -$0.07 | +53.33% | — | — |
| Q3 2022 Aug 15, 2022 | $2.67M | $8.75M | +227.21% | -$0.18 | -$0.11 | +38.89% | — | — |
| Q2 2022 May 16, 2022 | $15.50M | $16.09M | +3.77% | -$0.04 | -$0.05 | -25.00% | — | — |
| Q1 2022 Mar 31, 2022 | $7.79M | $8.55M | +9.74% | -$0.11 | -$0.14 | -27.27% | — | — |
| Q4 2021 Nov 15, 2021 | $7.79M | $12.05M | +54.74% | -$0.12 | -$0.09 | +25.00% | — | — |
| Q3 2021 Aug 16, 2021 | $6.90M | $6.43M | -6.86% | -$0.08 | -$0.25 | -212.50% | — | — |
| Q2 2021 May 14, 2021 | $10.95M | $11.32M | +3.38% | -$0.17 | -$0.14 | +17.65% | — | — |